Inhibrx Biosciences (INBX) Operating Margin (2023 - 2025)
Inhibrx Biosciences' (INBX) quarterly Operating Margin came in at 2106.85% in Q2 2025, up 15879115.0% year-on-year from N/an in Q2 2024, and up 95.78% on a QoQ basis from 49928.0% in Q4 2024.
Inhibrx Biosciences (INBX) Operating Margin (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Operating Margin data on file, last reported at 2106.85% in Q2 2025.
- On a quarterly basis, Operating Margin rose 15879115.0% year-over-year to 2106.85% in Q2 2025; TTM through Dec 2025 was 9644.64%, a 842777.0% increase from a year earlier, with the FY2025 full-year figure at 10386.54%, up 15533746.0% from the prior year.
- Operating Margin for Q2 2025 stood at 2106.85%, up from 49928.0% in the prior quarter.
- Over the last five years, Operating Margin for INBX reached as high as 2106.85% in Q2 2025 and fell as low as 160898.0% in Q2 2024.
- Historically, Operating Margin has averaged 65773.81% across 3 years, with a median of 44219.04% in 2023.
- Across the five-year window, Operating Margin slumped 4452476 bps in 2024 and jumped 15879115 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 5403.24% in 2023, then tumbled by 824 bps to 49928.0% in 2024, then soared by 96 bps to 2106.85% in 2025.
- Per Business Quant data, the three most recent Operating Margin figures were 2106.85% in Q2 2025, 49928.0% in Q4 2024, and 160898.0% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inhibrx Biosciences | 1.32 Bn | 1.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,106.85% |
| Dec 31, 2024 | -49,928.00% |
| Jun 30, 2024 | -160,898.00% |
| Dec 31, 2023 | -5,403.24% |
| Sep 30, 2023 | -38,510.08% |
| Jun 30, 2023 | -137,796.67% |